Company Overview

Nephro Care India Limited (NCIL) was incorporated in 2014 by Dr. Pratim Sengupta in Kolkata as a healthcare provider specializing in the treatment of kidney-related diseases. Originally incorporated on July 8, 2014, as "Nephro Care India Private Limited" with the Registrar of Companies, West Bengal, the company later converted into a Public Limited Company and was renamed "Nephro Care India Limited" with a fresh Certificate of Incorporation dated March 5, 2024.

NCIL provides comprehensive medical services for renal patients as a one-stop treatment center in Kolkata, offering clinical and lifestyle solutions for renal insufficiency, covering lifestyle, physiological, and spiritual wellness. The company specializes in non-invasive services and has positioned itself as a leading provider of kidney care services in Eastern India.

Business Operations and Services

Nephro Care India Limited operates Nephro Care clinics for the treatment of kidney-related diseases, offering kidney transplantation, diabetic kidney disease, hypertensive nephropathy, glomerular disease, lupus nephropathy, renal transplant clinic services, urology clinic services, vascular surgery clinic, hemodialysis, clinical nutrition and lifestyle education, lifestyle and rehabilitation program, digital radiology, cardiology, O.T. facility, and women welfare services.

At present, Nephro Care offers services at their clinics including:

- Inhouse Dialysis Unit

- Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology

- NABL accredited inhouse Pathology

- Inhouse Pharmacy

- Advance diagnostic facilities

- Renal Nutrition department

- Home Care

- Mukti (Lifestyle Support Program)

- Home Dialysis

The company started its flagship Salt Lake, Kolkata clinic in 2021 and expanded operations by starting two satellite clinics at Chandannagar, West Bengal in 2023, by taking up a Dialysis unit with e-Age Healthcare. The clinics have been equipped with technologically advanced equipment and diagnostic instruments.

Market Position and Market Capitalization

As of July 2025, Nephro Care India has a market capitalization of ₹235 crores. The company is almost debt-free, which provides it with financial flexibility and reduces its financial risk profile.

The company went public through a successful IPO listing on the NSE SME platform. Nephro Care India's IPO was subscribed 486.48 times, with the issue opening for bidding on June 28, 2024, and closing on July 2, 2024. The price band of the IPO was fixed between Rs 85 to Rs 90 per share. The IPO comprised a fresh issue of 45,84,000 equity shares, with promoter and promoter group shareholding diluted to 61.39% from 85.02% pre-issue.

Financial Performance

The company has demonstrated strong financial growth in recent years. Key financial metrics include:

- Revenue Growth:

- In 2023, Nephro Care India's revenue was ₹272.31 million, an increase of 59.31% compared to the previous year's ₹170.93 million.

- The company has an operating revenue of Rs. 49.57 Cr. on a trailing 12-month basis.

- Annual revenue growth of 61% is outstanding.

- Profitability:

- Earnings were ₹44.11 million in 2023, an increase of 85.94%.

- The company recorded revenue from operations of Rs 19.75 crore and net profit of Rs 3.40 crore for the nine months ended December 31, 2023.

- Pre-tax margin of 23% is great, ROE of 29% is exceptional.

- Recent Financial Data (as reported on July 10, 2025):

- Market Cap: ₹229 Crore (down -56.5% in 1 year)

- Revenue: ₹46.0 Cr

- Profit: ₹3.64 Cr

- Promoter Holding: 61.4%

Expansion Plans and Corporate Developments

The company intends to utilize the net proceeds from its IPO for setting up a multi-specialty hospital in the name of Vivacity Multi Specialty Hospital (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal, and for general corporate purposes.

On July 10, 2025, the Board approved the FY25 report, auditor appointments, AGM on August 28, SPV formation, and stockist proposal with Cadila Healthcare. This indicates the company's strategic initiatives to expand its operations and partnerships.

Workforce and Infrastructure

Currently, Nephro Care has 127 employees and maintains a team of doctors, paramedical staff, and a management team. The company also has its own daycare unit and offers services including dialysis, outpatient clinics with various specialists, pathology lab, pharmacy, diagnostics, nutritional counseling, and even home care.

Industry Context and Challenges

The high cost of dialysis care has led to financial hardship for practically all families with such patients. This presents both a challenge and an opportunity for Nephro Care India, as the company positions itself to provide accessible and comprehensive kidney care services.

The kidney care industry in India is growing due to the increasing prevalence of chronic kidney diseases, diabetes, and hypertension. Nephro Care India is well-positioned to capitalize on this growing demand with its comprehensive service offerings and strategic location in Eastern India.

Nephro Care India Limited represents a focused healthcare provider in the specialized kidney care segment, with strong financial performance, debt-free operations, and clear expansion plans. The company's comprehensive approach to renal care, combining medical treatment with lifestyle and wellness support, differentiates it in the competitive healthcare landscape.